03:16 AM EDT, 06/06/2024 (MT Newswires) -- Tighe Reardon, Acting Chief Financial Officer, on June 03, 2024, sold 822,721 shares in Janux Therapeutics ( JANX ) for $45,043,975. Following the Form 4 filing with the SEC, Reardon has control over a total of 3,515,007 shares of the company, with 174,989 shares held directly and 3,340,018 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1817713/000141588924015676/xslF345X03/form4-06052024_110615.xml

Price: 49.10, Change: +2.33, Percent Change: +4.98